Southeast Asian countries are perspective markets to export Russian pharmaceutical products.

JSC Pharmasyntez was on the pharma companies delegation, met under the auspices of the Ministry of Industry and Trade of Russia, and took part in a 2-hour meeting with a representative of the largest distributor in Thailand, Swiss company DKSH. The Thai market and DKSH Thailand are interested, first of all, in the original Russian products.

The Export Director, Pharmasyntez JSC expressed his interest in exporting to Thailand the innovation products, such as Saterex® (INN: Gosogliptine) for the treatment of type 2 diabetes mellitus, Serogard® for the treatment and prevention of adhesions at surgery, Perchlozone® for the treatment of multi-resistant tuberculosis. In addition, Y. Petrosyan supposed that there is an increasing interest in generic drugs in Thailand, which in turn makes this market more interesting for JSC Pharmasyntez.